A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery

Inclusion Criteria:

• Man or woman 18 years of age or older.
• Physically capable of instilling eye drop or have an appropriate person available toassist in administration of eye drops 4 times a day.
• Scheduled for phacoemulsification with intraocular lens (IOL) implantation for thetreatment of cataract.
• Meet the American Society of Anesthesiology (ASA) physical status I, II, or III and bemedically cleared for surgery.
• Willing to adhere to the prohibitions and restrictions specified in this protocol.
• Subjects must have signed an informed consent document indicating that they understandthe purpose of and procedures required for the study and are willing to participate inthe study.

Exclusion Criteria:

• Known allergy or contraindication to the test article(s) or their components.
• Presence of any abnormality or significant illness in the eye that in theinvestigator's opinion could affect the subject's health or the study parameters.
• Presence of an active ocular infection (bacterial, viral or fungal), or positivehistory of ocular herpetic infection.
• History of any significant illness that could be expected to interfere with the studyparameters. Any condition that, in the opinion of the investigator, would compromisethe well-being of the subject or the study.
• Use of disallowed therapies (systemic or topical):
• Fluoroquinolone anti-infective agents (systemic or topical) within 1 week ofVisit 1 or anytime after Visit 1 for the duration of the study.
• Use of contact lenses for one week prior to the study and for the duration of thestudy.
• Received an experimental drug or used an experimental medical device within 21 daysbefore the planned start of treatment.